Aurinia Pharmaceuticals Inc.
AUPH | NASDAQ
$16.74
+$0.13 (+0.78%)
Sep 22, 2026, 12:46 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 7.45 | 224.50 | -16.65 | -5.68 | -16.34 | -15.90 |
PEG Ratio | 0 | -2.09 | 0.58 | 0.12 | -0.27 | 0.46 |
PS Ratio | 7.57 | 5.46 | 7.34 | 4.57 | 64.88 | 32.69 |
PB Ratio | 3.69 | 3.40 | 3.41 | 1.51 | 6.18 | 4.02 |
P/FCF Ratio | 15.83 | 29.13 | -37.67 | -7.68 | -18.59 | -21.22 |
P/OCF Ratio | 15.80 | 28.94 | -38.48 | -7.71 | -18.76 | -23.45 |
OCF/S Ratio | 47.93 | 18.88 | -19.06 | -59.34 | -345.78 | -139.39 |
Debt / Equity Ratio | 0.13 | 0.21 | 0.26 | 0.02 | 0.02 | 0.02 |
Quick Ratio | 4.76 | 4.17 | 4.99 | 9.06 | 12.15 | 12.67 |
Current Ratio | 5.25 | 4.57 | 5.50 | 9.60 | 12.63 | 13.11 |
Asset Turnover | 0.38 | 0.43 | 0.32 | 0.28 | 0.08 | 0.11 |
Interest Coverage | 24.23 | -0.97 | -33.04 | n/a | n/a | n/a |
Return on Equity | 49.40% | 1.52% | -20.64% | -26.68% | -37.77% | -25.18% |
Return on Assets | 38.21% | 1.04% | -14.24% | -22.98% | -33.30% | -22.15% |
Return on Invested Capital | 15.53% | -0.77% | -18.85% | -26.19% | -35.88% | -24.09% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 88.46% | 87.99% | 91.94% | 95.77% | 97.61% | 100% |
Net Profit Margin | 101.47% | 2.45% | -44.45% | -80.71% | -396.81% | -204.88% |
Pretax Profit Margin | 40.33% | 3.17% | -44.14% | -79.35% | -395.15% | -205.06% |
Operating Profit Margin | 37.06% | -1.99% | -52.24% | -83.17% | -396.31% | -208.09% |
FCF Margin | 47.84% | 18.76% | -19.47% | -59.55% | -349.07% | -154.04% |
EBITDA Margin | 45.13% | 13.49% | -35.92% | -77.33% | -389.09% | -205.35% |
Add to Watchlist
Select watchlists to add or remove AUPH